Evaluating the Efficacy of Crisaborole Using the Atopic Dermatitis Severity Index and Percentage of Affected Body Surface Area

Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild-to-moderate atopic dermatitis. This post hoc analysis pools results from 2 phase 3 studies (ClinicalTrials.gov, NCT02118766 [AD-301]; NCT02118792 [AD-302]) to evaluate crisaborole efficacy in patients...

Descripción completa

Detalles Bibliográficos
Autores principales: SILVERBERG, Jonathan I., TALLMAN, Anna M., PORTS, William C., GERBER, Robert A., TAN, Huaming, ZIELINSKI, Michael A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Society for Publication of Acta Dermato-Venereologica 2020
Materias:
Clinical Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175045/
https://www.ncbi.nlm.nih.gov/pubmed/32318744
http://dx.doi.org/10.2340/00015555-3489

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9175045/
https://www.ncbi.nlm.nih.gov/pubmed/32318744
http://dx.doi.org/10.2340/00015555-3489

Ejemplares similares